The present invention provides compounds of formula I: (I) or a pharmaceutically acceptable derivative thereof, wherein R1, R2, A, G, and W are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of JNK, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli, Lck, Src, and Aurora kinases. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
本发明提供了化合物I的公式:(I)或其药用可接受的衍
生物,其中R1、R2、A、G和W如规范中所述。这些化合物是蛋白激酶的
抑制剂,特别是JNK的
抑制剂,JNK是一种参与细胞增殖、
细胞死亡和对细胞外刺激反应的哺乳动物蛋白激酶,还有Lck、Src和
Aurora激酶。该发明还涉及生产这些
抑制剂的方法。该发明还提供包括该发明的
抑制剂的药物组合物以及利用这些组合物在治疗和预防各种疾病中的方法。